Bayer says China approved Asundexian, making it the first Factor XIa inhibitor approved worldwide

Bayer says China approved Asundexian, making it the first Factor XIa inhibitor approved worldwide. The drug was previously approved in China for stroke prevention.

Detected & updated continuously · Source: Nebula